Efficacy of a Continuous GLP-1 Infusion Compared With a Structured Insulin Infusion Protocol to Reach Normoglycemia in Nonfasted Type 2 Diabetic Patients: A Clinical Pilot Trial

OBJECTIVE: Continuously administered insulin is limited by the need for frequent blood glucose measurements, dose adjustments, and risk of hypoglycemia. Regimens based on glucagon-like peptide 1 (GLP-1) could represent a less complicated treatment alternative. This alternative might be advantageous...

Descripción completa

Detalles Bibliográficos
Autores principales: Sourij, Harald, Schmölzer, Isabella, Kettler-Schmut, Eva, Eder, Michaela, Pressl, Helga, deCampo, Antonella, Wascher, Thomas C.
Formato: Texto
Lenguaje:English
Publicado: American Diabetes Association 2009
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2732139/
https://www.ncbi.nlm.nih.gov/pubmed/19528368
http://dx.doi.org/10.2337/dc09-0475

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2732139/
https://www.ncbi.nlm.nih.gov/pubmed/19528368
http://dx.doi.org/10.2337/dc09-0475

Ejemplares similares